To analyze tumor-associated macrophages (TAMs) and tumor-infiltrating immune lymphocytes from orthotopic PDAC arose in IL17A knock out mice or in wild-type mice treated or not with an anti-IL17A mAb, two 50 μm sections from a FFPE block were transferred into a gentle MACS C tube to be dissociated while preserving intact cells with the FFPE Tissue Dissociation Kit (130-118-052, Miltenyi Biotec, Bologna, Italy) following the manufacturer’s instructions. Five mice per group were analysed. Single cell suspensions were resuspended in PBS containing 0.5% BSA and 0.01% NaN3, and unspecific binding sites were blocked by 10 min incubation with anti-CD16/CD32 mAb (BioLegend, clone 93). Staining was performed using the following antibodies: FITC anti-CD11b (Miltenyi Biotec, clone M1/70.15.11.5), PerCP anti-CD45 (Miltenyi Biotec, clone 30F11), FITC anti-CD4 (Miltenyi Biotec, clone REA604), Per-CP anti-CD8 (eBioscience, clone 53-6.7), AF647anti-Granzyme-B (51-8898-82 eBioscience, clone NGZB), APC anti-CD206 (141712 BioLegend, clone C068C2), APC anti-FoxP3 (17-5773-82 eBioscience, clone FJK-16s) and APC anti-IFNγ (17-7311-82 eBioscience, clone XMG1.2). Cells were washed again with 0.5% BSA plus 0.01% NaN3 in PBS. For IFNγ, Granzyme-B and FoxP3 staining, cells were stained for surface markers, then fixed and permeabilized at 4 °C for 30 min with the Fixation Permeabilization kit (eBioscience) after several washes with 0.5% BSA plus 0.01% NaN3 in PBS. After washing with permeabilization buffer, antibodies against IFNγ, Granzyme-B and FoxP3 were added for 20 min at 4 °C. All flow cytometry data were acquired using the Accuri™ C6 cytometer (BD Biosciences, Milan, Italy) and analyzed with FlowJo_vX.0.7 software (Tree Star from BD Biosciences).
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.